Post stroke depression: epidemiology, pathophysiology, and biological treatment (Q34786798)

4 August 2017

1 reference

title

Post stroke depression: epidemiology, pathophysiology, and biological treatment (English)

1 reference

4 August 2017

1 reference

1 reference

Post stroke depression

1 reference

2

Benoit H Mulsant

1 reference

4 August 2017

1

Ellen M Whyte

1 reference

PubMed ID

12182931

4 August 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

4 August 2017

Biological Psychiatry

1 reference

4 August 2017

52

1 reference

4 August 2017

253-264

1 reference

4 August 2017

3

1 reference

Clinically defined vascular depression.

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Risk factors for post-stroke depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Generalized anxiety disorder in stroke patients. A 3-year longitudinal study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Major depression in stroke patients. A 3-year longitudinal study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Cognitive deficits in depression: possible implications for functional neuropathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Poststroke Depression in Acute Phase after Stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Poststroke bipolar affective disorder: clinical subtypes, concurrent movement disorders, and anatomical correlates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Manic delirium and frontal-like syndrome with paramedian infarction of the right thalamus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Risk factors for post-stroke depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Prevalence of depression after stroke: the Perth Community Stroke Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Major life events as risk factors for post-stroke depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Changes in cognitive functioning following treatment of late-life depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Depression after stroke and lesion location: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Secondary mania with focal cerebrovascular lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Electroconvulsive therapy for post-stroke depressed geriatric patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Therapy of early poststroke depression with venlafaxine: safety, tolerability, and efficacy as determined in an open, uncontrolled clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Longitudinal assessment of depression and cognitive impairment following stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Mood disorder following cerebrovascular accident

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Affective illness after stroke.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

The need for a new medical model: a challenge for biomedicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Are depressive symptoms nonspecific in patients with acute stroke?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Mood disorder as a specific complication of stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Incidence of silent cerebral infarction in patients with major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Background factors and clinical symptoms of major depression with silent cerebral infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Silent cerebral infarctions in patients with late-onset mania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Frequency, phenomenology and anatomical-clinical correlates of major post-stroke depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Depressive symptoms and history of depression predict rehabilitation efficiency in stroke patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

MRI signal hyperintensities in geriatric depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Depressive changes in stroke patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

The Sunnybrook Stroke Study: a prospective study of depressive symptoms and functional outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Depression associated with stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Mood disorders in the year after first stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Mortality at 12 and 24 months after stroke may be associated with depressive symptoms at 1 month.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Depression and frailty: the need for multidisciplinary research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Poststroke depression correlates with cognitive impairment and neurological deficits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

The prediction of major depression in women: toward an integrated etiologic model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Poststroke depression and emotional incontinence: correlation with lesion location.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Suicidal plans in patients with acute stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Suicidal plans in patients with stroke: comparison between acute-onset and delayed-onset suicidal plans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Psychological management of post-stroke depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Depression after stroke: results of the FINNSTROKE Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Hemiballismus and secondary mania following a right thalamic infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Post-stroke depression: combined treatment with imipramine or desipramine and mianserin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Methylphenidate and nortriptyline in the treatment of poststroke depression: a retrospective comparison

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Characterization of elderly patients in rehabilitation: stroke versus hip fracture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Nortriptyline treatment of post-stroke depression: a double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Phenomenological comparison of poststroke depression and functional depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Does stroke cause depression?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Depression and its relation to lesion location after stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Psychostimulants in post-stroke depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Frontal lobe dysfunction in secondary depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Association of depression with 10-year poststroke mortality.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Personality neuroticism and depression after stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

The relationship between risk factors for affective disorder and poststroke depression in hospitalised stroke patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Depression, Introversion and Mortality following Stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Are there two depressive syndromes after stroke?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

The relationship between self-rated health and depressive symptoms in an epidemiological sample of community-dwelling older adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Social origins of depression in old age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

A study of post-stroke depression in a rehabilitative center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Prevention of poststroke depression: 1 year randomised placebo controlled double blind trial of mianserin with 6 month follow up after therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Post-stroke depression, antidepressant treatment and rehabilitation results. A case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Vegetative and psychological symptoms associated with depressed mood over the first two years after stroke.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Gender differences in poststroke depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

The impact of poststroke depression on recovery in activities of daily living over a 2-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Life events and depression. A controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Frequency and clinical determinants of poststroke depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Functional impairment associated with acute poststroke depression: the Stroke Data Bank Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Antidepressant therapy after stroke. A double-blind trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Two-year longitudinal study of poststroke mood disorders: diagnosis and outcome at one and two years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Mood disorders in stroke patients. Importance of location of lesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Two-year longitudinal study of post-stroke mood disorders: comparison of acute-onset with delayed-onset depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Effect of experimental cerebral infarction in rat brain on catecholamines and behaviour

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

A two-year longitudinal study of post-stroke mood disorders: dynamic changes in associated variables over the first six months of follow-up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

A two year longitudinal study of mood disorders following stroke. Prevalence and duration at six months follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

A two-year longitudinal study of post-stroke mood disorders: findings during the initial evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Mood change following left hemispheric brain injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Poststroke depression and anxiety: different assessment methods result in variations in incidence and severity estimates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Association between depression and mortality in older adults: the Cardiovascular Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Depression in stroke rehabilitation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Does post-traumatic stress disorder occur after stroke: a preliminary study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Depressive disorders in long-term survivors of stroke. Associations with demographic and social factors, functional status, and brain lesion volume

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Functional and neuroanatomic correlations in poststroke depression: the Sunnybrook Stroke Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Post-stroke depression: relationships to functional impairment, coping strategies, and rehabilitation outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Assessment of depression in patients with brain pathology: the case of stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Anosognosia and major depression in 2 patients with cerebrovascular lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Depression after stroke: the importance of cerebral hemisphere asymmetries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Relationship between anxiety disorders and depressive disorders in patients with cerebrovascular injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Anosognosia in patients with cerebrovascular lesions. A study of causative factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Differential mood changes following basal ganglia vs thalamic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Mood changes after right-hemisphere lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Comparison of cortical and subcortical lesions in the production of poststroke mood disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Comparison of patients with and without poststroke major depression matched for size and location of lesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Cerebrovascular disease and depression symptoms in the cardiovascular health study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Magnetic resonance imaging correlates of depression after ischemic stroke.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Depressed mood after stroke. A community study of its frequency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Fluoxetine in early poststroke depression: a double-blind placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

Generalized anxiety disorder after stroke.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

7 January 2021

Methylphenidate in stroke patients with depression

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

7 January 2021

Dimensions of social impairment and their effect on depression and recovery following stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

7 January 2021

Poststroke depression and fluoxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901424-5

7 January 2021

10.1016/S0006-3223(02)01424-5

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12182931